We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock
search icon
We are thrilled to announce that the highly anticipated N-Nitroso impurities of Amide and Indole have now been successfully developed e.g. N-Nitroso Orlistat , N-Nitroso Ropinirole , N-Nitroso Caprolactam ,N-Nitroso Gabapentin EP Impurity A , N-Nitroso Rizatriptan , N-Nitroso Zolmitriptan, N-Nitroso Naratriptan , N-Nitroso Tadalafil , N-Nitroso Eletriptan etc. are ready Stock

Menu

Nitroso

Nitrosamines are a group of chemical compounds that contain the nitroso functional group (NO) attached to an amine group (-NH). They can form in various ways, including through industrial processes, combustion, and certain chemical reactions, particularly involving nitrites and secondary amines. Nitrosamines are of concern because Many nitrosamines (N-Nitrosamines) are potent genotoxins; some have been classified as possible human carcinogens, although the degree of risk can vary depending on factors such as the amount of exposure and individual susceptibility. Synchemia Research Chemical is dedicated to thoroughly investigating the formation of nitroso impurities in APIs, including those related to the manufacturing processes. This approach indicates a proactive stance toward quality control and regulatory compliance. By exploring all potential sources of nitroso impurities, including those arising from the production processes themselves, Synchemia Research Chemical demonstrates a commitment to ensuring the purity, safety, and efficacy of their pharmaceutical products. Nitrosoamines, including N-Des-methyl Nitroso impurities, are important in pharmaceutical research and development due to their potential impact on drug safety and efficacy. Understanding and controlling the presence of these impurities is crucial for ensuring the quality and safety of pharmaceutical products. Can N-Nitrosamines exist in two different stable forms? N-nitrosamines substituted with two different alkyl groups can exist in two different stable forms distinguishable by several analytical methods. The two rotamers may differ in their overall dipole moment and therefore may posses different chemical and physical properties. Why do I see two peaks when analyzing N-Nitrosamines by HPLC or GC? HPLC and GC)analysis of N-nitrosamines may show two rotamers of the N-nitrosamine as two separate peaks. Whether two peaks are observed depends on the structure of the N-nitrosamine (i.e., symmetric vs. asymmetric) as well as the separation power of the analytical method.
We are the Synchemia Research Chemical specializes in manufacturing and exporting various nitrosoamine compounds, particularly focusing on N-Des-methyl Nitroso impurities of various APIs and nitroso compounds of direct APIs that contain secondary amines. By specializing in the synthesis and export of these compounds, Synchemia Research likely plays a significant role in supporting the pharmaceutical industry's efforts to meet regulatory requirements and ensure the highest standards of quality and safety in drug manufacturing.
download image Download catalogue

Pharmaceutical Reference Standards

N-Nitrosoindoline
N-Nitrosoindoline
CAT No SRC-N014726
CAS No 7633-57-0
Mol.F. C8H8N2O
Mol.Wt. 148.2
INV STATUS IN STOCK
N-Nitroso Ropinirole EP Impurity D/N-Nitroso N-Despropyl Ropinirole
N-Nitroso Ropinirole EP Impurity D/N-Nitroso N-Despropyl Ropinirole
CAT No SRC-N014727
CAS No NA
Mol.F. C13H17N3O2
Mol.Wt. 247.3
INV STATUS IN STOCK
Dasatinib Nitroso Impurity 1
Dasatinib Nitroso Impurity 1
CAT No SRC-N014728
CAS No NA
Mol.F. C18H18ClN7O3S
Mol.Wt. 447.9
INV STATUS IN STOCK
N-Nitroso Silodosin Impurity
N-Nitroso Silodosin Impurity
CAT No SRC-N014729
CAS No NA
Mol.F. C25H31F3N4O5
Mol.Wt. 524.5
INV STATUS IN STOCK
Enzalutamide Nitroso Impurity 2
Enzalutamide Nitroso Impurity 2
CAT No SRC-N014730
CAS No NA
Mol.F. C12H14FN3O4
Mol.Wt. 283.3
INV STATUS IN STOCK
Ranolazine N-Nitroso N-Desacetamido Impurity
Ranolazine N-Nitroso N-Desacetamido Impurity
CAT No SRC-N014731
CAS No NA
Mol.F. C14H21N3O4
Mol.Wt. 295.3
INV STATUS IN STOCK
Methotrexate Nitroso Impurity 3
Methotrexate Nitroso Impurity 3
CAT No SRC-N014732
CAS No NA
Mol.F. C17H23N3O6
Mol.Wt. 365.4
INV STATUS IN STOCK
Methenamine Nitroso amine Impurity 1
Methenamine Nitroso amine Impurity 1
CAT No SRC-N014733
CAS No 13980-04-6
Mol.F. C3H6N6O3
Mol.Wt. 174.1
INV STATUS IN STOCK
N,N-Dinitrosopentamethylenetetramine
N,N-Dinitrosopentamethylenetetramine
CAT No SRC-N014734
CAS No 101-25-7
Mol.F. C5H10N6O2
Mol.Wt. 186.2
INV STATUS IN STOCK
N-Nitroso Fluvoxamine EP Impurity K
N-Nitroso Fluvoxamine EP Impurity K
CAT No SRC-N014735
CAS No NA
Mol.F. C16H23F3N4O2
Mol.Wt. 360.18
INV STATUS IN STOCK

Let’s advance your research together.

Partner with us for specialized chemical materials and synthesis services that enable pharmaceutical innovation.